2025 NextGen Webinars
March 2025
Title: Modulation of lipid nanoparticle-formulated plasmid DNA drives innate immune activation promoting adaptive immunity
Speaker: Nicholas Tursi, University of Pennsylvania Perelman School of Medicine
Title: Exploring Galsomes, adjuvanted mRNA-LNPs, for the development of more effective vaccines against Mycobacterium tuberculosis
Speaker: Ilke Aernout, Ghent University
Click Here to View the Recording
February 2025
Longitudinal Assessment of Human Immune Responses to Commercial Influenza Vaccination
Speaker: Dr. James Allen, Cleveland Clinic
Mentoring Session: Setting Up an Academic Lab; Opportunities and Challenges
January 2025
Improving Humoral Immunogenicity of Adenoviral Vector Vaccines by Capsid Display
Speaker: Alexander Sampson, Oxford University (Winner of 2024 ISV Annual Congress Bright Sparks Competition)
Entrepreneurship and Biotech Start-Up
2024 NextGen Webinars
December 2024
Peripheral co delivery of plasmid encoded mucosal chemokine CCL27 enhances mucosal immunity and supports protection from heterologous SARS CoV 2 and H5N1 influenza virus challenges
Speaker: Dr. Ebony Gary, The Wistar Institute
Industry Session: Computational Vaccinology
November 2024
Journey from Academia to Industry
Speaker: Dr. Sandra Depelsenaire, Vaxxas
Career Overview
September 2024
Skills and Opportunities for Early Career Researchers in the Biomedical Industry
Speaker: Dr Danilo Casimiro, Chief Scientific Officer and Global Head, External Affairs, Sanofi Vaccines
Understanding the Pre-Vaccination Immune Landscape to Identify Biomarkers of Vaccine Responsiveness
